Table 2.
Univariate and multivariable analysis for overall survival (all patients).
Variables | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | ||
Sex | Male | 1 | 1 | ||||
Female | 3.539 | 1.624 - 7.320 | 0.0009 | 4.526 | 1.934 - 10.18 | 0.0003 | |
Age | ≥60 | 1 | 1 | ||||
<60 | 1.879 | 0.9796 - 3.849 | 0.0680 | 1.735 | 0.8321 - 3.847 | 0.1551 | |
Primary site | Oral cancer | 1 | 1 | ||||
Oropharyngeal cancer | 0.8634 | 0.2535 - 2.237 | 0.2716 | 0.5177 | 0.1416 - 1.504 | 0.2633 | |
Laryngeal cancer | 0.6493 | 0.2136 - 1.610 | 0.8551 | 0.6374 | 0.1841 - 1.888 | 0.4405 | |
Hypopharynx cancer | 1.304 | 0.3082 - 3.762 | 0.4302 | 0.8184 | 0.1709 - 2.890 | 0.7750 | |
Nasal and sinus cancer | 1.351 | 0.4972 - 3.121 | 0.6538 | 1.058 | 0.3693 - 2.606 | 0.9081 | |
Tumor site | Local recurrence | 1 | 1 | ||||
Distant metastasis | 0.6940 | 0.2279 - 1.735 | 0.4715 | 0.5959 | 0.1702 - 1.719 | 0.3731 | |
Both | 2.155 | 1.088 - 4.152 | 0.0234 | 1.795 | 0.8298 - 3.756 | 0.1266 | |
Immunotherapy | Yes | 1 | 1 | ||||
No | 0.6337 | 0.2175 - 1.475 | 0.3400 | 0.5312 | 0.1757 – 1.319 | 0.2090 | |
CDKN2A | WT | 1 | 1 | ||||
LOF | 2.114 | 1.154 - 3.973 | 0.0168 | 2.311 | 1.156 - 4.748 | 0.0194 |
HR, hazard ratio; CI, confidence interval; LOF, loss-of-function; WT, wild-type.